Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
US Department of Justice
Fish and Richardson
Julphar
Boehringer Ingelheim
Cipla

Generated: March 25, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Dasotraline

« Back to Dashboard

US Patents for Dasotraline

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Dasotraline ➤ Sign Up Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide Sepracor Inc. (Marlborough, MA) ➤ Sign Up
Dasotraline ➤ Sign Up Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide Sepracor Inc. (Marlborough, MA) ➤ Sign Up
Dasotraline ➤ Sign Up Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Sepracor Inc. (Marlborough, MA) ➤ Sign Up
Dasotraline ➤ Sign Up Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Sepracor Inc. (Marlborough, MA) ➤ Sign Up
Dasotraline ➤ Sign Up Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Sepracor Inc. (Marlborough, MA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Dasotraline

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Dasotraline Australia 2003272460 2022-09-16 ➤ Sign Up
Dasotraline Brazil 0314377 2022-09-16 ➤ Sign Up
Dasotraline Canada 2498152 2022-09-16 ➤ Sign Up
Dasotraline China 100584818 2022-09-16 ➤ Sign Up
Dasotraline China 101712626 2022-09-16 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Covington
Julphar
Citi
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
 NCE-1 Generic Application Dates 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: